An interventional study of WisePath for Adults and Active-Control app + electronic wellness resources brochure in Suicide, Suicide, Attempted and Suicidal Ideation, sponsored by Evidence-Based Practice Institute, Seattle, WA. Completed at 1 site in United States. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2026-04-17.
Sponsored by Evidence-Based Practice Institute, Seattle, WA · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 149 studies in Suicide, Attempted with a site in United States — 53 open to participants now, 58 under way, 1 of them phase 3. Suicide, Attempted · United States.
Among the 149 studies in Suicide, Attempted with a site in United States, this one is the 65th largest by enrollment of the 140 interventional ones that give a count, is one of 15 that started in 2025, is one of 121 with no phase, and was the 96th registered.
281 studies on the registry are indexed under Suicide, Attempted; 90 are open to participants now.
Browse Suicide, Attempted studies →53 of the 149 studies in Suicide, Attempted with a site in United States are open now. Recruiting first, the newest first:
Dartmouth-Hitchcock Medical Center · Sites in United States
Ages 12+
Massachusetts General Hospital · Sites in United States
Ages 18+
University of Texas Southwestern Medical Center · Sites in United States
Ages 13–17
University of Michigan · Sites in United States
Ages 18–65
Ohio State University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 67 Suicide, Attempted studies recruiting now, 34 (51%) set no upper age limit and 32 (48%) stop at 75 or younger; 28 take children under 18; 11 take healthy volunteers.
This study: 22 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
149 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 8 · Phase 3 6 · Phase 4 3
First in 1999; this study’s year is marked. 15 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 127 is close to the median of 129 across 224 interventional studies indexed under Suicide, Attempted.
Median enrollment 117 across the 140 interventional studies, 225 across the 7 observational. Of the 87 that completed or were terminated, 30 (34%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 149 have an industry lead sponsor. The 10 most frequent:
Evidence-Based Practice Institute, Seattle, WA is the lead sponsor of 8 studies on the registry; 1 is open to participants now.
Evidence-Based Practice Institute, Seattle, WA has 1 study filed under Suicide, Attempted — fewer than ten, so there is no comparison to draw.
30 of the studies in Suicide, Attempted with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04763343Phase 3Tatiana Falcone, MDKetamine Treatment of Youth Suicide Attempters | 2027-02-28 |
| NCT07170657University of Texas Southwestern Medical CenterTeen Recovery Through Inspiration, Support, and Empowerment | 2026-11 |
| NCT06460220Jennifer HughesSAFETY-Parent: Online Learning Module to Support Parents of Suicidal Youth | 2026-12 |
| NCT06285708Ohio State UniversityEnhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals With PTSD | 2026-12 |
| NCT04578938Rebecca PriceKetamine + Cognitive Training for Suicidality in the Medical Setting | 2026-12-02 |
Add all 30 to your calendar (.ics) → With an account.
Among the 149 studies in Suicide, Attempted with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The central purpose of this project is to evaluate and facilitate access to evidence-based best practices for individuals struggling with suicidal ideation and co-occurring behavioral problems, including alcohol misuse, and provide assistance to the patients while they are waiting to receive care, as they are receiving care, and after they return home. While WisePath is highly innovative in how it delivers these best practices, the content is well-established and known to reduce suicidality and alcohol misuse.
We will conduct a 12-week intent-to-treat RCT with 120 suicidal adults 22 years and older who may also be experiencing alcohol misuse. Participants will be randomly assigned to WisePath (n=60) or an active control condition (n=60) including a control suicide prevention self-help app plus an electronic wellness resources brochure containing links to health and wellness materials, psychoeducation about suicide, depression, self-help recovery-focused resources (e.g., Alcoholics Anonymous and other 12-Step programs, Moderation Management, etc.), and phone/text information for the 988 Suicide \& Crisis Lifeline. Participants will be assessed at baseline, 4, 8 and 12 weeks.
This study will test the newly developed WisePath for Adults ("WisePath"), a robust digital technology developed under NIAAA SBIR Fast-Track award (R44AA029868; Drs. Dimeff \& Jobes, Co-PIs) that is developed to efficiently and reliably aid delivery of recommended best-practices for the treatment of suicidal ideation in adults, including suicidal individuals who also misuse alcohol. WisePath includes techniques for prevention of suicidal behaviors (ideation, planning, attempts) while providing access to support resources in the moment via a mobile app. WisePath will include evidence-based practices for suicide prevention, including for those who are suicidal and also experience other behavioral health concerns such as depressed mood, sleep problems, and misuse of alcohol. This study will test WisePath with individuals who are experiencing these problems and recently sought treatment from a primary care provider. WisePath includes: psychoeducation, behavioral skills training, crisis stabilization planning, lethal means management, brief interventions for the treatment of suicidal ideation, depressed mood, sleep problems, alcohol misuse, and messages of hope, wisdom, and insights from people with lived experience (PLE).
We will conduct a randomized controlled trial (RCT; N=120) comparing WisePath (n=60) to an active control condition (a well-regarded suicide prevention self-help app + electronic wellness resources brochure; n=60) in adults experiencing suicidal ideation. To ensure a sufficient sample of individuals who misuse alcohol, no fewer than 35% (n=42) of the sample will be comprised of individuals who experience a harmful or hazardous level of alcohol use. Participants will be randomly assigned to a condition utilizing a minimization randomization procedure to match participants across condition on suicide severity, depression severity, and alcohol misuse. Participants will be assessed at baseline, 4, 8, and 12 weeks.
We hypothesize that in comparison to the active control condition, WisePath participants will show significantly better outcomes from baseline to the 4-, 8-, and 12-week assessment points such that:
281 studies on the registry are indexed under Suicide, Attempted; 90 are open to participants now.
This study's enrollment of 127 is close to the median of 129 across 224 interventional studies indexed under Suicide, Attempted.
Browse Suicide, Attempted studies →Evidence-Based Practice Institute, Seattle, WA is the lead sponsor of 8 studies on the registry; 1 is open to participants now.
Compared within Suicide, Attempted, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Suicide. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Endorsement of any ASQ items 1 -3 (expanded from "past few weeks" in ASQ to "past 30 days" in our measures)
Given that alcohol misuse exponentially increases the risk of death by suicide, can exacerbate other problems, and interfere with effective treatment, we will over-recruit individuals who misuse alcohol to ensure relevance of the tool for them. No fewer than 35% of the sample will be comprised of individuals who score 8 or more on the Alcohol Use Disorders Identification Test (AUDIT), indicating a harmful or hazardous level of drinking.
To ensure a sufficient sample of individuals who misuse alcohol, no fewer than 35% of the sample will be comprised of individuals who score 8 or more on the Alcohol Use Disorders Identification Test (AUDIT), indicating a harmful or hazardous level of drinking.
Exclusion Criteria:
Individuals who are excluded because of the severity of their depression, suicide acuity, and/or degree of substance use disorder will be provided with resources (i.e., the Suicide and Crisis Lifeline (988), SAMHSA's National Helpline) and encouraged to reach out to their primary care or mental/behavioral health provider.
WisePath is designed to help support individuals during challenging moments and while experiencing behavioral concerns. The app is designed for people who struggle with depression, sleep problems, have feelings of wanting to die, or want to harm themselves, and/or misuse alcohol. WisePath includes specific tools for those who are experiencing suicidality, including creating a safety plan and teaching skills and strategies to get through distressing moments. You have been assigned to use the WisePath app while you are in this study.
Device: WisePath for Adults
Well-regarded suicide prevention self-help app, plus an electronic wellness resources brochure containing links to health and wellness materials, psychoeducation about suicide, depression, self-help recovery-focused resources (e.g., Alcoholics Anonymous, other 12-Step programs, Moderation Management, etc.), and phone/text information for the National Suicide Prevention Lifeline.
Device: Active-Control app + electronic wellness resources brochure
Participants assigned to this condition will receive access to the WisePath app for 12 weeks.
Participants assigned to this condition will receive access to Virtual Hope Box, a well-regarded suicide prevention self-help app, for 12 weeks plus an electronic wellness resources brochure.
Change in Self-Injurious Thoughts and Behaviors Interview-Revised
A structured interview, which can also be delivered as a self-report measure, containing modules that assess suicidal ideation, suicide plans, suicide gestures, suicide attempts, and non-suicidal self injury. The SITBI has excellent psychometric properties, with inter-rater reliability coefficients in the range of 1.0 and strong test-retest reliability over six months. The SITBI correlates highly and in expected directions with other suicidal ideation measures and is behaviorally specific. Peak Suicidal Ideation Intensity, Suicide Plan Forecasting, and Suicide Attempt Forecasting are scored on a 5-point scale (0=Low/Little; 4=Very much/Severe). Higher scores indicate higher intensity of suicidal ideation and greater likelihood to make a suicide plan and attempt.
Time frame: Baseline (time 1), 4 weeks (time 2), 8 weeks (time 3), 12 weeks (time 4)
Change in Self-Injurious Thoughts and Behaviors Interview-Revised
A structured interview, which can also be delivered as a self-report measure, containing modules that assess suicidal ideation, suicide plans, suicide gestures, suicide attempts, and non-suicidal self injury. The SITBI has excellent psychometric properties, with inter-rater reliability coefficients in the range of 1.0 and strong test-retest reliability over six months. The SITBI correlates highly and in expected directions with other suicidal ideation measures and is behaviorally specific. Past 30-Day Suicidal Ideation Frequency refers to the number of times in the past month the behavior occurred. A higher number indicates a greater number of suicidal thoughts experienced in the last month.
Time frame: Baseline (time 1), 4 weeks (time 2), 8 weeks (time 3), 12 weeks (time 4)
Change in Suicide-Related Coping Scale
17-item, with 5 items scored in reverse, psychometrically-sound self-report measure of coping with suicidal thoughts, urges, and crises that uses a 5-point rating scale (0=strongly disagree; 4=strongly agree). There are two subscales, internal coping (minimum of 0 and maximum of 28) and external coping (minimum of 0 and maximum of 28). Subscale items are summed to generate total scores for each. Higher subscale scores indicate higher ability to cope with suicidality.
Time frame: Baseline (time 1), 4 weeks (time 2), 8 weeks (time 3), 12 weeks (time 4)
Change in the Patient-Reported Outcome Measurement Information System (PROMIS)
A well-validated, normed set of measures with standardized scoring. The measures of alcohol use (minimum of 0 and maximum of 28) and negative consequences related to alcohol use (minimum of 0 and maximum of 28) have 7 items. The measure of self-efficacy to manage emotions (minimum of 0 and maximum of 16) has 4 items. All measures are scored on a 5-point scale, (i.e., 0=never and 4=almost always for the alcohol use and negative consequences related to alcohol use measures; 0=I am not at all confident and 4=I am very confident for the self-efficacy to manage emotions measure), and responses are summed to create a raw total score for each measure. Higher scores for each measure indicate greater alcohol use, negative consequences related to alcohol use, and higher self-efficacy to manage emotions.
Time frame: Baseline (time 1), 4 weeks (time 2), 8 weeks (time 3), 12 weeks (time 4)
App Satisfaction Survey
An eight-item survey used in EBPI's earlier research, which focuses on an app's ease of use and helpfulness. The initial six items use a five-point rating scale (1=poor; 5=excellent). Users also provide an overall satisfaction rating for their condition app using a 100-point scale (1=the worst; 100=the best) and indicate whether they would recommend using the app to others in their situation. The scores for the initial six items were also summed and averaged to generate the Average of Satisfaction Items score. Higher scores indicate the app has greater ease of use and helpfulness, and the respondent felt more cared about, supported, likely to recommend the app, and greater satisfaction with the app.
Time frame: 12 weeks (time 4)
Alcohol Use Disorders Identification Test (AUDIT)
A 10-item psychometrically sound self-report measure (minimum 0 and maximum 40) used to assess alcohol intake, potential dependence on alcohol, and experience of alcohol-related harm. Items 1-8 are scored on a 5-point scale (0=Never to 4=Daily or almost daily; 0=Never to 4=4 or more times a week; 0=1 or 2 to 4=10 or more). Items 9 and 10 are scored on a 3-point scale (0=No; 2=Yes, but not in the last year; 4=Yes, during the last year). Items are summed to generate a total score. A score of 0 suggests no experience with problems related to alcohol use; 1 to 7 suggests low-risk consumption; 8 to 14 suggest hazardous or harmful alcohol consumption; and 15 or more indicates the likelihood of alcohol dependence.
Time frame: Eligibility Screen (Time 0)
Drug Abuse Screening Test (DAST-10)
A 10-item psychometrically validated self-administered screening tool (minimum of 0 and maximum of 10) for drug-related problems. Items are scored on a binary scale. (No=0; Yes=1), except for item 3 which is reverse scored. Items are summed to generate a total score. Higher scores indicate a greater degree of problems related to drug use.
Time frame: Eligibility Screen (Time 0)
Patient Health Questionnaire-9 (PHQ-9)
The nine-item questionnaire assesses recent depressive symptoms, and has excellent sensitivity (.77 to .86) and specificity (.78 to .95) in detecting major depression. Scores of 1-9 indicate minimal to mild depression; 10-14, moderate depression; and 15-19, moderate to severe depression.
Time frame: Eligibility Screen (Time 0)
Participants were recruited through primary care clinics and a third-party organization, User Interviews.
| Milestone | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| Started | 64 | 63 |
| Completed | 61 | 61 |
| Not completed | 3 | 2 |
A structured interview, which can also be delivered as a self-report measure, containing modules that assess suicidal ideation, suicide plans, suicide gestures, suicide attempts, and non-suicidal self injury. The SITBI has excellent psychometric properties, with inter-rater reliability coefficients in the range of 1.0 and strong test-retest reliability over six months. The SITBI correlates highly and in expected directions with other suicidal ideation measures and is behaviorally specific. Peak Suicidal Ideation Intensity, Suicide Plan Forecasting, and Suicide Attempt Forecasting are scored on a 5-point scale (0=Low/Little; 4=Very much/Severe). Higher scores indicate higher intensity of suicidal ideation and greater likelihood to make a suicide plan and attempt.
| Scores on a scale | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| Suicide Plan Forecasting Time 1 | 0.92 ± 1.0 | 1.05 ± 1.0 |
| Suicide Plan Forecasting Time 2 | 0.62 ± 0.9 | 0.74 ± 0.9 |
| Suicide Plan Forecasting Time 3 | 0.66 ± 1.0 | 0.65 ± 0.9 |
| Suicide Plan Forecasting Time 4 | 0.65 ± 1.0 | 0.48 ± 0.9 |
| Suicide Attempt Forecasting Time 1 | 0.84 ± 0.9 | 0.78 ± 0.8 |
| Suicide Attempt Forecasting Time 2 | 0.64 ± 0.9 | 0.52 ± 0.7 |
| Suicide Attempt Forecasting Time 3 | 0.58 ± 1.0 | 0.40 ± 0.7 |
| Suicide Attempt Forecasting Time 4 | 0.46 ± 0.8 | 0.32 ± 0.6 |
| Peak Suicidal Ideation Intensity Time 1 | 1.98 ± 1.3 | 2.11 ± 1.7 |
| Peak Suicidal Ideation Intensity Time 2 | 1.64 ± 1.5 | 1.10 ± 1.3 |
| Peak Suicidal Ideation Intensity Time 3 | 1.25 ± 1.4 | 1.15 ± 1.4 |
| Peak Suicidal Ideation Intensity Time 4 | 1.12 ± 1.4 | 1.13 ± 1.4 |
A structured interview, which can also be delivered as a self-report measure, containing modules that assess suicidal ideation, suicide plans, suicide gestures, suicide attempts, and non-suicidal self injury. The SITBI has excellent psychometric properties, with inter-rater reliability coefficients in the range of 1.0 and strong test-retest reliability over six months. The SITBI correlates highly and in expected directions with other suicidal ideation measures and is behaviorally specific. Past 30-Day Suicidal Ideation Frequency refers to the number of times in the past month the behavior occurred. A higher number indicates a greater number of suicidal thoughts experienced in the last month.
| Events | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| Past 30-Day Suicidal Ideation Frequency Time 1 | 4.98 ± 6.1 | 4.14 ± 6.4 |
| Past 30-Day Suicidal Ideation Frequency Time 2 | 3.16 ± 5.7 | 2.58 ± 6.3 |
| Past 30-Day Suicidal Ideation Frequency Time 3 | 2.13 ± 4.7 | 2.45 ± 6.4 |
| Past 30-Day Suicidal Ideation Frequency Time 4 | 2.42 ± 5.7 | 1.49 ± 4.4 |
17-item, with 5 items scored in reverse, psychometrically-sound self-report measure of coping with suicidal thoughts, urges, and crises that uses a 5-point rating scale (0=strongly disagree; 4=strongly agree). There are two subscales, internal coping (minimum of 0 and maximum of 28) and external coping (minimum of 0 and maximum of 28). Subscale items are summed to generate total scores for each. Higher subscale scores indicate higher ability to cope with suicidality.
| Score on a scale | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| External Coping Time 1 | 19.16 ± 4.6 | 19.15 ± 5.2 |
| External Coping Time 2 | 20.47 ± 4.9 | 20.29 ± 5.4 |
| External Coping Time 3 | 21.49 ± 5.4 | 21.89 ± 4.6 |
| External Coping Time 4 | 21.85 ± 5.1 | 22.15 ± 4.8 |
| Internal Coping Time 1 | 20.29 ± 4.6 | 19.40 ± 5.3 |
| Internal Coping Time 2 | 20.90 ± 5.1 | 21.47 ± 4.5 |
| Internal Coping Time 3 | 21.98 ± 4.6 | 22.00 ± 4.8 |
| Internal Coping Time 4 | 23.20 ± 4.5 | 22.41 ± 4.7 |
An eight-item survey used in EBPI's earlier research, which focuses on an app's ease of use and helpfulness. The initial six items use a five-point rating scale (1=poor; 5=excellent). Users also provide an overall satisfaction rating for their condition app using a 100-point scale (1=the worst; 100=the best) and indicate whether they would recommend using the app to others in their situation. The scores for the initial six items were also summed and averaged to generate the Average of Satisfaction Items score. Higher scores indicate the app has greater ease of use and helpfulness, and the respondent felt more cared about, supported, likely to recommend the app, and greater satisfaction with the app.
| Score on a scale | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| Overall Satisfaction | 68.50 ± 23.56 | 60.08 ± 26.58 |
| Ease of Use | 3.75 ± 1.16 | 3.80 ± 0.91 |
| Helpfulness | 3.07 ± 1.29 | 2.84 ± 1.25 |
| Felt Cared About | 2.68 ± 1.30 | 2.26 ± 1.11 |
| Received Help or Support | 2.87 ± 1.35 | 2.52 ± 1.32 |
| Recommendation Likelihood | 2.87 ± 1.31 | 2.93 ± 1.42 |
| Rating of Care | 3.35 ± 1.23 | 2.72 ± 1.17 |
| Average of Satisfaction Items | 3.18 ± 1.11 | 2.85 ± 1.02 |
A 10-item psychometrically sound self-report measure (minimum 0 and maximum 40) used to assess alcohol intake, potential dependence on alcohol, and experience of alcohol-related harm. Items 1-8 are scored on a 5-point scale (0=Never to 4=Daily or almost daily; 0=Never to 4=4 or more times a week; 0=1 or 2 to 4=10 or more). Items 9 and 10 are scored on a 3-point scale (0=No; 2=Yes, but not in the last year; 4=Yes, during the last year). Items are summed to generate a total score. A score of 0 suggests no experience with problems related to alcohol use; 1 to 7 suggests low-risk consumption; 8 to 14 suggest hazardous or harmful alcohol consumption; and 15 or more indicates the likelihood of alcohol dependence.
| Score on a scale | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| Alcohol Use Disorders Identification Test (AUDIT) | 7.95 ± 7.8 | 7.08 ± 6.7 |
A 10-item psychometrically validated self-administered screening tool (minimum of 0 and maximum of 10) for drug-related problems. Items are scored on a binary scale. (No=0; Yes=1), except for item 3 which is reverse scored. Items are summed to generate a total score. Higher scores indicate a greater degree of problems related to drug use.
| Score on a scale | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| Drug Abuse Screening Test (DAST-10) | 1.31 ± 1.5 | 0.95 ± 1.2 |
The nine-item questionnaire assesses recent depressive symptoms, and has excellent sensitivity (.77 to .86) and specificity (.78 to .95) in detecting major depression. Scores of 1-9 indicate minimal to mild depression; 10-14, moderate depression; and 15-19, moderate to severe depression.
| Score on a scale | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| Patient Health Questionnaire-9 (PHQ-9) | 11.75 ± 5.1 | 11.46 ± 5.2 |
A well-validated, normed set of measures with standardized scoring. The measures of alcohol use (minimum of 0 and maximum of 28) and negative consequences related to alcohol use (minimum of 0 and maximum of 28) have 7 items. The measure of self-efficacy to manage emotions (minimum of 0 and maximum of 16) has 4 items. All measures are scored on a 5-point scale, (i.e., 0=never and 4=almost always for the alcohol use and negative consequences related to alcohol use measures; 0=I am not at all confident and 4=I am very confident for the self-efficacy to manage emotions measure), and responses are summed to create a raw total score for each measure. Higher scores for each measure indicate greater alcohol use, negative consequences related to alcohol use, and higher self-efficacy to manage emotions.
| Score on a scale | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| Alcohol Use Time 1 | 10.05 ± 8.8 | 9.86 ± 8.2 |
| Alcohol Use Time 2 | 7.26 ± 7.8 | 7.24 ± 8.2 |
| Alcohol Use Time 3 | 6.29 ± 7.1 | 5.45 ± 7.3 |
| Alcohol Use Time 4 | 5.67 ± 6.8 | 5.61 ± 7.1 |
| Negative Alcohol Use Consequences Time 1 | 8.11 ± 7.4 | 8.40 ± 7.0 |
| Negative Alcohol Use Consequences Time 2 | 5.57 ± 5.7 | 5.85 ± 6.2 |
| Negative Alcohol Use Consequences Time 3 | 4.80 ± 5.2 | 4.40 ± 5.6 |
| Negative Alcohol Use Consequences Time 4 | 4.38 ± 5.0 | 4.41 ± 5.0 |
| Emotion Self-Efficacy Time 1 | 11.97 ± 3.1 | 11.76 ± 3.4 |
| Emotion Self-Efficacy Time 2 | 12.26 ± 3.1 | 13.31 ± 3.4 |
| Emotion Self-Efficacy Time 3 | 12.86 ± 3.1 | 13.81 ± 3.3 |
| Emotion Self-Efficacy Time 4 | 12.72 ± 3.2 | 14.21 ± 3.2 |
Collected over 12 weeks. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| WisePath for Adults | 0/64 (0%) | 0/64 (0%) | 36/64 (56.3%) |
| Active-Control App + Electronic Wellness Resources Brochure | 0/63 (0%) | 0/63 (0%) | 35/63 (55.6%) |
| Event | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| Suicide attempt that leads to acute hospital-based carePsychiatric disorders | 0/64 | 0/63 |
| Alcohol poisoning that leads to acute hospital-based carePsychiatric disorders | 0/64 | 0/63 |
| Event | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure |
|---|---|---|
| Significant increase in suicidal ideation frequencyPsychiatric disorders | 16/64 | 14/63 |
| Self-report of blackouts related to alcohol usePsychiatric disorders | 13/64 | 10/63 |
| Significant increase in alcohol usePsychiatric disorders | 9/64 | 10/63 |
| Significant increase in negative consequences related to alcohol usePsychiatric disorders | 9/64 | 8/63 |
| Significant increase in suicidal ideation intensityPsychiatric disorders | 7/64 | 7/63 |
| Self-report of injuries to themselves or others related to alcohol usePsychiatric disorders | 4/64 | 3/63 |
| Warm Handoff to 988Psychiatric disorders | 3/64 | 1/63 |
| Suicide attempts that do not require medical attention or hospital-based carePsychiatric disorders | 0/64 | 1/63 |
| Suicide attempt that leads to acute hospital-based care (e.g., ED visit)Psychiatric disorders | 0/64 | 0/63 |
All participants completed Baseline (Time 1).
| Age, Categorical(Participants) | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 64 | 60 | 124 |
| >=65 years | 0 | 3 | 3 |
| Sex/Gender, Customized(Participants) | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure | Total |
|---|---|---|---|
| Female | 34 | 37 | 71 |
| Male | 27 | 25 | 52 |
| Nonbinary | 3 | 1 | 4 |
| Race/Ethnicity, Customized(Participants) | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure | Total |
|---|---|---|---|
| White | 32 | 35 | 67 |
| Black | 22 | 19 | 41 |
| Asian or Asian American | 9 | 7 | 16 |
| American Indian or Alaskan Native | 7 | 4 | 11 |
| Native Hawaiian or Other Pacific Islander | 2 | 0 | 2 |
| Other | 6 | 7 | 13 |
| Region of Enrollment(Participants) | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure | Total |
|---|---|---|---|
| United States | 64 | 63 | 127 |
| Hispanic/Latinx(Participants) | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure | Total |
|---|---|---|---|
| Hispanic/Latinx | 13 | 13 | 26 |
| Not Hispanic/Latinx | 51 | 50 | 101 |
| Mental Health Treatment(Participants) | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure | Total |
|---|---|---|---|
| Not engaged in mental health treatment | 33 | 33 | 66 |
| 2 or less hours a week | 30 | 29 | 59 |
| 3 or more hours a week | 1 | 1 | 2 |
| Employment(Participants) | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure | Total |
|---|---|---|---|
| Employed | 50 | 46 | 96 |
| Unemployed | 14 | 17 | 31 |
| Lifetime Suicide Attempts(Participants) | WisePath for Adults | Active-Control App + Electronic Wellness Resources Brochure | Total |
|---|---|---|---|
| None | 40 | 38 | 78 |
| 1-2 | 10 | 11 | 21 |
| 3 or more | 14 | 14 | 28 |
1 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Requests for use of data will be considered on a case-by-case basis. Interested researchers may send data requests to research@jasprhealth.com. The final dataset will include self-reported demographic and behavioral data from participants in the randomized controlled trial. The dataset will include sensitive data from participants regarding suicidal behavior and substance use. Even though the final dataset will be stripped of identifiers prior to release for sharing, investigators believe that there remains the possibility of deductive disclosure of participants. Thus, the de-identified dataset will be distributed by Drs. Dimeff and Jobes to those that request it and only under a data-sharing agreement that includes: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate security protections; and (3) a commitment to destroying the data after analyses are completed.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Study data will become available after grant closeout, in perpetuity.
Access criteria: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate security protections; and (3) a commitment to destroying the data after analyses are completed.
Ran from Mar 2025 to primary completion in Nov 2025, 8 months.
Results were first posted in Apr 2026, 5 months after primary completion.
Of 147 interventional studies with no phase under Suicide, Attempted, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 56. This study's 8 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Evidence-Based Practice Institute, Seattle, WA